These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23964854)

  • 41. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA; Higgins TJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
    Rydén L; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Packer M; Poole-Wilson PA
    Eur Heart J; 2000 Dec; 21(23):1967-78. PubMed ID: 11071803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accidental pediatric ingestion, hospital charges and failure to utilize a poison control center.
    Stremski ES
    WMJ; 1999 Nov; 98(7):29-33. PubMed ID: 10638290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ; Ramsay LE; Hettiarachchi J
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of lisnopril, an angiotensin converting enzyme (ACE) inhibitor on spermatogenesis in rats.
    Okeahialam BN; Amadi K; Ameh AS
    Arch Androl; 2006; 52(3):209-13. PubMed ID: 16574603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review.
    Beuhler MC; Spiller HA; Sasser HC
    J Med Toxicol; 2010 Mar; 6(1):4-8. PubMed ID: 20213217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses.
    Agarwal R; Lewis R; Davis JL; Becker B
    Am J Kidney Dis; 2001 Dec; 38(6):1245-50. PubMed ID: 11728957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril.
    Izzo JL; Yedlapati SH; Faheem SM; Younus U; Osmond PJ
    J Am Soc Hypertens; 2012; 6(6):399-404. PubMed ID: 23107894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997-2008.
    Armenian P; Kearney TE
    Clin Toxicol (Phila); 2014 Mar; 52(3):214-9. PubMed ID: 24528175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.
    Davidson NC; Coutie WJ; Webb DJ; Struthers AD
    Heart; 1996 Jun; 75(6):576-81. PubMed ID: 8697160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can a poison center overdose guideline safely reduce pediatric emergency department visits for unintentional β-blocker ingestions?
    Hickey CN; Mycyk MB; Wahl MS
    Am J Ther; 2012 Sep; 19(5):346-50. PubMed ID: 21192245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of bittering agents on pediatric ingestions of antifreeze.
    White NC; Litovitz T; Benson BE; Horowitz BZ; Marr-Lyon L; White MK
    Clin Pediatr (Phila); 2009 Nov; 48(9):913-21. PubMed ID: 19571333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxic clonidine ingestion in children.
    Spiller HA; Klein-Schwartz W; Colvin JM; Villalobos D; Johnson PB; Anderson DL
    J Pediatr; 2005 Feb; 146(2):263-6. PubMed ID: 15689921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cases of pediatric ingestion of celecoxib reported to Texas poison control centers in 2000-2007.
    Forrester MB
    Hum Exp Toxicol; 2009 Apr; 28(4):191-4. PubMed ID: 19734269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
    Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining the risk of methanol poisoning from methyl acetate-containing products.
    Minns AB; McIlvoy A; Clark A; Clark RF; Cantrell FL
    Am J Emerg Med; 2013 Jun; 31(6):964-6. PubMed ID: 23602747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Large Case Series of Acute Pediatric Methotrexate Ingestions: Significant Clinical Effects Are Rare.
    Hensley MD; Bebarta VS; Borys DJ
    Pediatr Emerg Care; 2016 Oct; 32(10):682-684. PubMed ID: 27383404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin converting enzyme inhibitor ingestion in children.
    Spiller HA; Udicious TM; Muir S
    J Toxicol Clin Toxicol; 1989; 27(6):345-53. PubMed ID: 2576459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of intravenous lipid emulsion in patients with acute glyphosate intoxication.
    Gil HW; Park JS; Park SH; Hong SY
    Clin Toxicol (Phila); 2013; 51(8):767-71. PubMed ID: 23869655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.